Developing an applied model for making decisions towards the end of life about care for someone with dementia.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 20 11 2020
accepted: 16 05 2021
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 27 10 2021
Statut: epublish

Résumé

Many people with dementia reach the end-of-life without an advance care plan. Many are not ready to have conversations about end-of-life, and decision-making is left to their families and professionals when they no longer have capacity. Carers may benefit from further support with decision-making. To develop this support, it is important to understand the decision-making process. Explore with family carers and people living with dementia the decision-making process and factors that influence decision-making in dementia end of life care, to produce a model of decision-making in the context of dementia end-of-life care. Semi-structured interviews with 21 family carers and 11 people with dementia in England (2018-2019) from memory clinics, general practice and carer organisations. Interviews were analysed using thematic analysis and findings were mapped onto the Interprofessional Shared Decision Making model, refined to produce a modified model of decision-making in dementia. Participants described five key decisions towards the end-of-life as examples of decision making. We used these experiences to produce a modified model of decision-making in dementia end-of-life-care. The model considers the contextual factors that influence the decision-making process, including: personal preferences; advance care planning and Lasting Power of Attorney; capacity and health and wellbeing of the person with dementia; support from others and clarity of roles. The decision-making process consists of seven inter-linked stages: 1) identifying the decision maker or team; 2) sharing and exchanging information; 3) clarifying values and preferences; 4) managing and considering emotions; 5) considering the feasibility of options; 6) balancing preferred choice and the actual choice; and 7) implementation and reflecting on outcomes. The modified model breaks down the decision-making process and attempts to simplify the process while capturing the subtle nuances of decision making. It provides a framework for conversations and supporting decisions by carers.

Sections du résumé

BACKGROUND
Many people with dementia reach the end-of-life without an advance care plan. Many are not ready to have conversations about end-of-life, and decision-making is left to their families and professionals when they no longer have capacity. Carers may benefit from further support with decision-making. To develop this support, it is important to understand the decision-making process.
AIM
Explore with family carers and people living with dementia the decision-making process and factors that influence decision-making in dementia end of life care, to produce a model of decision-making in the context of dementia end-of-life care.
METHODS
Semi-structured interviews with 21 family carers and 11 people with dementia in England (2018-2019) from memory clinics, general practice and carer organisations. Interviews were analysed using thematic analysis and findings were mapped onto the Interprofessional Shared Decision Making model, refined to produce a modified model of decision-making in dementia.
RESULTS
Participants described five key decisions towards the end-of-life as examples of decision making. We used these experiences to produce a modified model of decision-making in dementia end-of-life-care. The model considers the contextual factors that influence the decision-making process, including: personal preferences; advance care planning and Lasting Power of Attorney; capacity and health and wellbeing of the person with dementia; support from others and clarity of roles. The decision-making process consists of seven inter-linked stages: 1) identifying the decision maker or team; 2) sharing and exchanging information; 3) clarifying values and preferences; 4) managing and considering emotions; 5) considering the feasibility of options; 6) balancing preferred choice and the actual choice; and 7) implementation and reflecting on outcomes.
CONCLUSIONS
The modified model breaks down the decision-making process and attempts to simplify the process while capturing the subtle nuances of decision making. It provides a framework for conversations and supporting decisions by carers.

Identifiants

pubmed: 34043728
doi: 10.1371/journal.pone.0252464
pii: PONE-D-20-36588
pmc: PMC8158904
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0252464

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

BMC Geriatr. 2020 Dec 2;20(1):520
pubmed: 33267831
Dementia (London). 2016 Sep;15(5):1141-57
pubmed: 25370075
Int Psychogeriatr. 2020 Jun;32(6):753-763
pubmed: 32241317
Dementia (London). 2019 Oct-Nov;18(7-8):2985-3003
pubmed: 29544346
Palliat Med. 2014 Mar;28(3):197-209
pubmed: 23828874
Palliat Med. 2014 Mar 13;28(7):919-930
pubmed: 24625567
Int J Palliat Nurs. 2017 Jan 2;23(1):4-11
pubmed: 28132606
Health Aff (Millwood). 2016 Apr;35(4):619-26
pubmed: 27044961
PLoS One. 2018 Nov 14;13(11):e0206422
pubmed: 30427873
BMC Palliat Care. 2016 Jul 07;15:55
pubmed: 27388766
Dementia (London). 2019 Apr;18(3):825-845
pubmed: 27821714
BMJ. 2005 Apr 30;330(7498):1007-11
pubmed: 15860828
Int J Geriatr Psychiatry. 2017 Sep;32(9):1037-1045
pubmed: 27515899
Palliat Med. 2019 Mar;33(3):259-261
pubmed: 30758274
J Eval Clin Pract. 2011 Aug;17(4):554-64
pubmed: 20695950
Dementia (London). 2019 Jul;18(5):1601-1614
pubmed: 28766384
Am J Geriatr Psychiatry. 2010 Mar;18(3):193-203
pubmed: 20224516
BMC Psychiatry. 2018 Sep 24;18(1):307
pubmed: 30249213
Int Psychogeriatr. 2020 Oct;32(10):1245-1248
pubmed: 32349850
Lancet Oncol. 2017 Sep;18(9):e543-e551
pubmed: 28884703
Health Expect. 2018 Feb;21(1):118-127
pubmed: 28640487
BMJ Open. 2016 Jul 19;6(7):e010416
pubmed: 27436665
Aging Ment Health. 2014 May;18(4):400-10
pubmed: 24131061
BMJ. 2010 Aug 18;341:c4184
pubmed: 20719843
Int Psychogeriatr. 2019 Oct;31(10):1403-1419
pubmed: 31347482
J Adv Nurs. 2002 Feb;37(4):382-6
pubmed: 11872108
Health Expect. 2018 Dec;21(6):1111-1121
pubmed: 30073734
Palliat Med. 2013 May;27(5):409-17
pubmed: 23128905
J Aging Stud. 2013 Apr;27(2):143-50
pubmed: 23561279
Palliat Med. 2019 Mar;33(3):274-290
pubmed: 30404576
Am J Geriatr Psychiatry. 2018 Mar;26(3):316-331
pubmed: 29426607
Gerontologist. 2019 Sep 17;59(5):822-834
pubmed: 30007366
J Nurs Scholarsh. 2000;32(3):251-8
pubmed: 12462819
Palliat Med. 2017 Sep;31(8):726-733
pubmed: 27815555

Auteurs

Nathan Davies (N)

Centre for Ageing Population Studies, Research Department of Primary Care and Population Health, University College London, London, United Kingdom.
Centre for Dementia Palliative Care Research, Division of Psychiatry, Marie Curie Palliative Care Research Department, University College London, London, United Kingdom.

Tanisha De Souza (T)

Centre for Ageing Population Studies, Research Department of Primary Care and Population Health, University College London, London, United Kingdom.

Greta Rait (G)

Centre for Ageing Population Studies, Research Department of Primary Care and Population Health, University College London, London, United Kingdom.

Jessica Meehan (J)

Centre for Ageing Population Studies, Research Department of Primary Care and Population Health, University College London, London, United Kingdom.

Elizabeth L Sampson (EL)

Centre for Dementia Palliative Care Research, Division of Psychiatry, Marie Curie Palliative Care Research Department, University College London, London, United Kingdom.
Barnet Enfield and Haringey Mental Health Trust Liaison Team, North Middlesex University Hospital, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH